# Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis

> **NCT01943006** · PHASE3 · COMPLETED · sponsor: **Medinova AG** · enrollment: 144 (actual)

## Conditions studied

- Thrombophlebitis
- Phlebitis

## Interventions

- **DRUG:** Hirudoid cream 0.3 % Mucopolysaccharide polysulfate
- **DRUG:** Placebo cream without active substance

## Key facts

- **NCT ID:** NCT01943006
- **Lead sponsor:** Medinova AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-02
- **Final completion:** 2017-03
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2017-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01943006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01943006, "Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01943006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*